Glucagon-like peptide 1 (GLP-1) Mol Metab
GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R
This effect is not observed in other GLP-1RAs and is currently being studied by the drug manufacturers in the FOCUS trial (NCT03811561)
You book a video visit with a licensed provider who reviews your health history, evaluates your candidacy for GLP-1 therapy, and if appropriate, prescribes your medication during the visit
Anyone, whether theyre a Ro patient or not, can use the GLP-1 Insurance Coverage Checker to get a personalized results report that: Details their insurance coverage for each GLP-1 medication, including whether their policy requires prior authorization
It preserves muscle mass, supports metabolic health, stabilizes glucose, and protects bone density